| Literature DB >> 27246393 |
Heng Zhang1, Yaqian Huang2, Dingfang Bu3, Selena Chen4, Chaoshu Tang5,6, Guang Wang1, Junbao Du2,6, Hongfang Jin2.
Abstract
The present study was designed to determine whether sulfur dioxide (SO2) could be endogenously produced in adipocyte and served as a novel adipocyte-derived inflammatory inhibitor. SO2 was detected in adipose tissue using high-performance liquid chromatography with fluorescence detection. SO2 synthase aspartate aminotransferase (AAT1 and AAT2) mRNA and protein expressions in adipose tissues were measured. For in vitro study, 3T3-L1 adipocytes were cultured, infected with adenovirus carrying AAT1 gene or lentivirus carrying shRNA to AAT1, and then treated with tumor necrosis factor-α (TNF-α). We found that endogenous SO2/AAT pathway existed in adipose tissues including perivascular, perirenal, epididymal, subcutaneous and brown adipose tissue. AAT1 overexpression significantly increased SO2 production and inhibited TNF-α-induced inflammatory factors, monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) secretion from 3T3-L1 adipocytes. By contrast, AAT1 knockdown decreased SO2 production and exacerbated TNF-α-stimulated MCP-1 and IL-8 secretion. Mechanistically, AAT1 overexpression attenuated TNF-α-induced IκBα phosphorylation and degradation, and nuclear factor-κB (NF-κB) p65 phosphorylation, while AAT1 knockdown aggravated TNF-α-activated NF-κB pathway, which was blocked by SO2. NF-κB inhibitors, PDTC or Bay 11-7082, abolished excessive p65 phosphorylation and adipocyte inflammation induced by AAT1 knockdown. This is the first report to suggest that endogenous SO2 is a novel adipocyte-derived inflammatory inhibitor.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27246393 PMCID: PMC4887903 DOI: 10.1038/srep27026
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The AAT/SO2 system in rat adipose tissues (mean ± SEM).
(a) SO2 content in rat tissue homogenate (perivascular adipose tissue, perirenal adipose tissue, epididymal adipose tissue, subcutaneous adipose tissue, brown adipose tissue, heart, lung, liver, spleen, kidney and aorta) by HPLC-FD. (b) RT-PCR analysis of AAT1 and AAT2 mRNA levels in rat tissue (perivascular adipose tissue, perirenal adipose tissue, epididymal adipose tissue, subcutaneous adipose tissue, brown adipose tissue, heart, lung, liver, spleen, kidney and aorta). (c) Western blot analysis of AAT1 and AAT2 protein expression in rat tissue homogenate (perivascular adipose tissue, perirenal adipose tissue, epididymal adipose tissue, subcutaneous adipose tissue, brown adipose tissue, heart, lung, liver, spleen, kidney and aorta). The bands of AAT1 and AAT2 were exposed twice. (d) Measurement of SO2 production from different rat tissues by addition of L-cysteine plus pyridoxal 5′-phosphate to tissue homogenate and incubation for 90 min. (e) Expression of AAT1 in different rat tissues using immunohistochemistry: i, perivascular adipose tissue; ii, perirenal adipose tissue; iii, epididymal adipose tissue; iv, subcutaneous adipose tissue; v, brown adipose tissue; vi, heart; vii, liver; viii, aorta; and ix IgG as a negative control. (f) Expression of AAT2 in different rat tissues using immunohistochemistry: i, perivascular adipose tissue; ii, perirenal adipose tissue; iii, epididymal adipose tissue; iv, subcutaneous adipose tissue; v, brown adipose tissue; vi, heart; vii, liver; viii, aorta; and ix IgG as a negative control. (g) Hematoxylin and eosin (HE) staining of different rat tissues: i, perivascular adipose tissue; ii, perirenal adipose tissue; iii, epididymal adipose tissue; iv, subcutaneous adipose tissue; v, brown adipose tissue; vi, heart; vii, liver; and viii aorta.
Figure 2AAT1 overexpression decreased MCP-1 and IL-8 secretion from TNF-α-induced 3T3-L1 adipocytes.
(a) Protein expression of AAT1 in 3T3-L1 adipocytes infected with AAT1 adenovirus (Ad-AAT1, 100 moi) or Ad-Control. (b) SO2 production in 3T3-L1 adipocytes. (c) SO2 level in supernatant of 3T3-L1 adipocytes infected with Ad-AAT1 or Ad-Control by HPLC-FD. (d,e) MCP-1 (d) and IL-8 (e): relative concentration in supernatant from 3T3-L1 adipocytes by ELISA. Adipocytes were infected with Ad-Control or Ad-AAT1 for 3 d, and then stimulated with TNF-α (10 ng/ml) for 2 h. Data are means ± SEM of 6 independent experiments. *P < 0.05 compared with Ad-Control group; **P < 0.01 compared with Ad-Control group; #P < 0.05 compared with Ad-Control + TNF-α group; ##P < 0.01 compared with Ad-Control + TNF-α group.
Figure 3AAT1 knockdown exacerbated MCP-1 and IL-8 secretion from TNF-α-stimulated 3T3-L1 adipocytes.
(a) Protein expression of AAT1 in 3T3-L1 adipocytes infected with lentivirus carrying shRNA to AAT1 (sh-AAT1, 100 moi) or sh-Control. (b) SO2 production in 3T3-L1 adipocytes. (c) SO2 level in supernatant of 3T3-L1 adipocytes infected with sh-AAT1 or sh-Control by HPLC-FD. (d,e) MCP-1 (d) and IL-8 (e): relative concentration in supernatant from 3T3-L1 adipocytes by ELISA. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then stimulated with TNF-α (10 ng/ml) for different times. (f,g) MCP-1 (f) and IL-8 (g): relative concentration in supernatant from 3T3-L1 adipocytes by ELISA. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then stimulated with TNF-α (10 ng/ml) for 2 h. Data are means ± SEM of 6 independent experiments. *P < 0.05 compared with sh-Control group; **P < 0.01 compared with sh-Control group; #P < 0.05 compared with sh-Control + TNF-α group; ##P < 0.01 compared with sh-Control + TNF-α group.
Figure 4Endogenous SO2 inhibited NF-κB pathway activation in TNF-α-stimulated 3T3-L1 adipocytes.
(a) NF-κB p65 phosphorylation, IκBα phosphorylation and degradation in TNF-α-induced 3T3-L1 adipocytes. Adipocytes were infected with Ad-Control or Ad-AAT1 for 3 d, and then stimulated with TNF-α (10 ng/ml) for 30 min. Data are means ± SEM of 4 independent experiments. **P < 0.01 compared with Ad-Control group; ##P < 0.01 compared with Ad-Control + TNF-α group. (b) NF-κB p65 phosphorylation in 3T3-L1 adipocytes. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then stimulated with TNF-α (10 ng/ml) for different times. (c) NF-κB p65 phosphorylation, IκBα phosphorylation and degradation in TNF-α-stimulated 3T3-L1 adipocytes. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then stimulated with TNF-α (10 ng/ml) for 30 min. (d) NF-κB p65 phosphorylation in 3T3-L1 adipocytes. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, pretreated with SO2 derivatives (NaHSO3/Na2SO3, 100 μmol/L) for 1 h, and then stimulated with TNF-α (10 ng/ml) for 30 min. Data are means ± SEM of 4 independent experiments. *P < 0.05 compared with sh-Control group; **P < 0.01 compared with sh-Control group; #P < 0.05 compared with sh-Control + TNF-α group; ##P < 0.01 compared with sh-Control + TNF-α group; &P < 0.05 compared with sh-AAT1 group; +P < 0.05 compared with sh-AAT1 + TNF-α group.
Figure 5The activation of NF-κB pathway mediated aggravation of MCP-1 and IL-8 secretion in 3T3-L1 adipocytes with AAT1 knockdown.
(a) NF-κB p65 phosphorylation in 3T3-L1 adipocytes. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then treated with PDTC (10 μmol/L) or Bay 11-7082 (10 μmol/L) for 2 h. (b–c) MCP-1 (b) and IL-8 (c): relative concentration in supernatant from 3T3-L1 adipocytes by ELISA. Adipocytes were infected with sh-Control or sh-AAT1 for 4 d, and then treated with PDTC (10 μmol/L) or Bay 11-7082 (10 μmol/L) for 2 h. Data are means ± SEM of 4 independent experiments. *P < 0.05 compared with sh-Control group; #P < 0.05 compared with sh-AAT1 group.